Fulgent Genetics has a low Price/Book ratio and promising drug candidates. Key trial results are expected in May 2025. Read ...

Discover the top 5 undervalued Health Care Providers & Services stocks for Wednesday, March 12 based on AAII’s Stock Grades.

Proficio Capital Partners LLC bought a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the ...

The market was down 3.1% for the week and down 2.9% YTD. We are now back to where we started on election day in November 2024 ...

StockNews.com upgraded shares of Fulgent Genetics (NASDAQ:FLGT – Free Report) from a sell rating to a hold rating in a research report released on Wednesday. Separately, Piper Sandler decreased their ...

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their ...

Paul Kim, the CFO and Treasurer of $FLGT, bought 100,000 shares of the company on 03-05-2025 for an estimated $1,596,470. This trade was reported by Quiver ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

John Silas: Good morning. This is John Silos, a member of the Investor Relations team for Goldman Sachs BDC, Inc. And I would like to welcome everyone to the Goldman Sachs BDC, Inc. Fourth Quarter ...

Operator: Welcome to the MBIA Inc. Fourth Quarter and Full Year 2024 Financial Results Conference Call. I would now like to turn the call over to Greg Diamond, Managing Director of Investor and ...